Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jul 12, 2012
Boston Scientific Corporation (NYSE: BSX) will webcast its second-quarter 2012 financial results conference call on Thursday, July 26, at 8:00 a.m....
-
Jul 2, 2012Milestone Marks Next Step Toward FDA Submission for Stroke Reduction Device for Patients with Atrial Fibrillation
Boston Scientific Corporation (NYSE: BSX) has completed enrollment in the PREVAIL confirmatory study, designed to gain U.S. Food and Drug...
-
Jun 26, 2012
Boston Scientific Corporation (NYSE: BSX) welcomes final passage today by the United States Senate of "The Food and Drug Administration Safety and...
-
Jun 14, 2012
Natick, MA (June 14, 2012) –Warren Wang has been appointed Vice President and Managing Director of Boston Scientific Corporation’s (NYSE:BSX) operations in China. Mr. Wang is responsible for...
-
Jun 14, 2012Boston Scientific Announces First Patient Active with LATITUDE™ NXT Remote Patient Management System
Next-generation wireless remote patient management system enabled for INGENIO™ family of pacemakers is now in use in Europe
-
Jun 8, 2012
Adds first and only commercially available subcutaneous ICD technology that offers new life-saving therapy option to patients at risk of sudden cardiac arrest.
-
Jun 7, 2012
Medical device tax would stifle innovation
-
Jun 6, 2012
Event to be webcast live and will include detailed review of Bronchial Thermoplasty opportunity.
-
Jun 4, 2012
PROMUS Element plus stent system offers physicians the broadest array of Everolimus drug-eluting stent lengths and diameters in the U.S.
-
May 31, 2012
Devices projected to have nearly twice the longevity of comparable products
-
May 29, 2012
Indication provides new therapeutic option for extraction of difficult-to-manage biliary stones
-
May 18, 2012
Seven abstracts and data analyses to be presented May 19 – 22 in San Diego.
-
May 18, 2012
Two-year clinical data demonstrate low adverse event rates, including no myocardial infarction or stent thrombosis, for the Boston Scientific 2.25 mm PROMUS Element Platinum Chromium Stent
-
May 17, 2012
New self-expanding Nitinol stent offers balance of flexibility and radial strength for enhanced performance in iliac stenting procedures.
-
May 15, 2012
Follow-up data from EVOLVE Trial presented at EuroPCR.
-
May 15, 2012
Results of REPRISE I study suggest device minimizes aortic regurgitation
-
May 14, 2012
Innovative stent designed to treat peripheral vascular lesions for stenoses in arteries above the knee.
-
May 14, 2012
Collaboration expected to improve access to imaging data used to treat patients.
-
May 11, 2012
Results presented at Heart Rhythm Society from ASA Plavix study evaluating Boston Scientific Left Atrial Appendage Closure Device.
-
May 10, 2012
Clinical presentations to include 12-month outcomes data from EVOLVE trial and results of the REPRISE I trial.
-
May 7, 2012
Advanced pacemaker platform designed to treat chronotropic incompetence, which affects up to 42 percent of pacemaker patients.
-
May 3, 2012
Clinical presentations will provide new insights for physicians who treat patients with heart disorders including sudden cardiac arrest, atrial fibrillation and heart failure.
-
Apr 26, 2012
A live webcast and replay of the May 8 session will be available. Read more.
-
Apr 24, 2012
Next-generation balloon catheter offers enhanced deliverability and expanded options for treating coronary artery lesions.
-
Apr 23, 2012
REPRISE I Trial Results to be Presented at EuroPCR 2012